Knowing how well vaccination against one SARS-Co-V2 strain (with or without previous infection) counteracts infection with a different strain is a critical research question. The answers could guide strategies to continue to subdue the COVID pandemic, even as the coronavirus regains ground.
Recent scientific studies in this area have been led by the labs of David Veesler, associate professor of biochemistry at the University of Washington in Seattle and Howard Hughes Medical Institute Investigator, and Davide Corti of Humabs BioMed SA of Vir Biotechnology in Switzerland.
Their latest findings appear in this week’s Science magazine in the paper “Imprinted antibody response against SARS-CoV-2 Omiron sublineages.”
